Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Immunology/Infectious Diseases
Disease Category: Cytomegalovirus Infections
Trial Information
A Phase I Dose Escalation Study of Peptide Vaccines with Activity Against Human Cytomegalovirus
You have been asked to take part in this research study because you are a healthy adult who may be eligible for a study about vaccines for human cytomegalovirus (CMV) or because you were in study protocol #97092. The purpose of this study is to find out the safety and the best dose of two types of CMV vaccines, alone or with something added, called CPG 7909 for Injection (CPG 7909). Your participation in this study will last up to 12 months.
Patient Inclusion/Exclusion Criteria:
- See http://clinicaltrials.coh.org for additional information.
City of Hope
1500 East Duarte Road
Duarte, CA 91010-3000
Phone: 866-896-HOPE (4673)
View Google Map
Research Center Information: City of Hope
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
